Merck has just registered the 15th…
Merck has just registered the 15th global phase 3 trial [...]
Though spending on pharmaceutical…
Though spending on pharmaceutical TV ads picked up last month [...]
Early Monday, Roche announced that…
Early Monday, Roche announced that the FDA cleared its 12-year-old [...]
Novartis has shared detailed data…
Novartis has shared detailed data showing its radioligand therapy Pluvicto [...]
After upstaging Keytruda as…
After upstaging Keytruda as monotherapy for the treatment of first-line [...]
More than two years after a…
More than two years after a positive topline readout, AstraZeneca [...]
Merck offered a closer look at…
Merck offered a closer look at Keytruda’s overall survival benefits [...]
The FDA has endorsed Amgen and…
The FDA has endorsed Amgen and AstraZeneca’s Tezspire as an [...]
Fertility drugmaker EMD Serono,…
Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, [...]
In the first opportunity for…
In the first opportunity for industry watchers to compare the [...]